Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.
Tailor D, Resendez A, Garcia-Marques FJ, Pandrala M, Going CC, Bermudez A, Kumar V, Rafat M, Nambiar DK, Honkala A, Le QT, Sledge GW, Graves E, Pitteri SJ, Malhotra SV.
Tailor D, et al.
Cell Chem Biol. 2021 Aug 19;28(8):1206-1220.e6. doi: 10.1016/j.chembiol.2021.02.014. Epub 2021 Mar 12.
Cell Chem Biol. 2021.
PMID: 33713600
Free article.